Delcath Systems, Inc. (DCTH)
NASDAQ: DCTH · Real-Time Price · USD
11.11
+0.23 (2.11%)
At close: Aug 13, 2025, 4:00 PM
10.90
-0.21 (-1.89%)
Pre-market: Aug 14, 2025, 8:48 AM EDT
Delcath Systems Revenue
Delcath Systems had revenue of $24.16M in the quarter ending June 30, 2025, with 211.05% growth. This brings the company's revenue in the last twelve months to $70.24M, up 491.35% year-over-year. In the year 2024, Delcath Systems had annual revenue of $37.21M with 1,701.69% growth.
Revenue (ttm)
$70.24M
Revenue Growth
+491.35%
P/S Ratio
5.19
Revenue / Employee
$731,667
Employees
96
Market Cap
388.64M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 37.21M | 35.14M | 1,701.69% |
Dec 31, 2023 | 2.07M | -654.00K | -24.05% |
Dec 31, 2022 | 2.72M | -836.00K | -23.52% |
Dec 31, 2021 | 3.56M | 1.91M | 115.98% |
Dec 31, 2020 | 1.65M | 66.00K | 4.18% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
DCTH News
- 7 days ago - Delcath Systems, Inc. (DCTH) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Delcath Systems Reports Second Quarter 2025 Results and Business Highlights - Business Wire
- 15 days ago - Delcath Systems to Participate at the Canaccord Genuity 45th Annual Growth Conference - Business Wire
- 19 days ago - Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 21 days ago - Delcath Systems to Host Second Quarter 2025 Earnings Call - Business Wire
- 2 months ago - Delcath Systems: Growing Fast, But Business Model Is Fragile - Seeking Alpha
- 3 months ago - Delcath Systems Issues Full Year 2025 Guidance - Business Wire
- 3 months ago - Delcath Systems: Q1 Earnings Show A Growth Spurt And Switch To Execution - Seeking Alpha